- Home
- TSQ vs PLX Comparison
TSQ vs PLX Comparison
Compare TSQ & PLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSQ
- PLX
- Stock Information
- Founded
- TSQ 1996
- PLX 1993
- Country
- TSQ United States
- PLX United States
- Employees
- TSQ N/A
- PLX N/A
- Industry
- TSQ Broadcasting
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TSQ Consumer Discretionary
- PLX Health Care
- Exchange
- TSQ Nasdaq
- PLX Nasdaq
- Market Cap
- TSQ 113.6M
- PLX 122.6M
- IPO Year
- TSQ 2000
- PLX 1998
- Fundamental
- Price
- TSQ $7.46
- PLX $1.41
- Analyst Decision
- TSQ Buy
- PLX Strong Buy
- Analyst Count
- TSQ 1
- PLX 1
- Target Price
- TSQ $13.00
- PLX $15.00
- AVG Volume (30 Days)
- TSQ 109.2K
- PLX 652.0K
- Earning Date
- TSQ 08-06-2025
- PLX 08-13-2025
- Dividend Yield
- TSQ 10.74%
- PLX N/A
- EPS Growth
- TSQ N/A
- PLX N/A
- EPS
- TSQ N/A
- PLX 0.05
- Revenue
- TSQ $450,024,000.00
- PLX $59,764,000.00
- Revenue This Year
- TSQ N/A
- PLX $65.02
- Revenue Next Year
- TSQ $6.28
- PLX $57.34
- P/E Ratio
- TSQ N/A
- PLX $30.42
- Revenue Growth
- TSQ N/A
- PLX 0.18
- 52 Week Low
- TSQ $6.47
- PLX $0.82
- 52 Week High
- TSQ $12.32
- PLX $3.10
- Technical
- Relative Strength Index (RSI)
- TSQ 63.25
- PLX 37.71
- Support Level
- TSQ $7.05
- PLX $1.32
- Resistance Level
- TSQ $7.53
- PLX $1.44
- Average True Range (ATR)
- TSQ 0.21
- PLX 0.09
- MACD
- TSQ 0.05
- PLX 0.02
- Stochastic Oscillator
- TSQ 90.00
- PLX 27.27
About TSQ Townsquare Media Inc.
Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.